La mayoría de los clérigos concurren con la ciencia sobre el tratamiento para la depresión, según un estudio
VIERNES, 13 de enero de 2023 (HealthDay News) — Las preocupaciones de que los clérigos insten a sus congregantes deprimidos a confiar en la oración, y no en otros tipos de atención de la salud mental, parecen carecer de fundamento.Una encuesta nacion…
Learn MoreIn Tibetan Monk Study, Hints That Meditating Can Alter Gut Microbes
TUESDAY, Jan. 17, 2023 (HealthDay News) — Meditation might help a person’s gut health — but it takes a lot of meditation over a long time.Tibetan Buddhist monks appear to have gut microbes that differ substantially from others living near them, a new…
Learn MoreAHA News: Dr. Ralph Sacco – First Neurologist to Serve as AHA President – Dies at 65
TUESDAY, Jan. 17, 2023 (American Heart Association News) — Between his first and second years of medical school, before he was certain about what he’d specialize in, Ralph Sacco landed a job alongside Dr. Philip Wolf.Sacco’s role included feeding pun…
Learn MoreCOPD Patients Have Lower Survival, Increased Costs After Surgery
TUESDAY, Jan. 17, 2023 (HealthDay News) — Patients with chronic obstructive pulmonary disease (COPD) undergoing elective surgery have lower survival and increased costs in the year following surgery, according to a study published online Jan. 17 in C…
Learn MoreAcupuncture, Acupressure Beneficial in Gynecologic Cancer Surgery Setting
TUESDAY, Jan. 17, 2023 (HealthDay News) — Preoperative touch/relaxation and intraoperative acupuncture treatments are effective for reducing anxiety and pain in the gynecological oncology surgical setting, according to a study published online Jan. 1…
Learn MoreConvalescent COVID-19 Plasma Beneficial for Immunocompromised
TUESDAY, Jan. 17, 2023 (HealthDay News) — Transfusion of convalescent COVID-19 plasma is associated with a reduction in mortality for immunocompromised patients, according to a systematic review published online Jan. 12 in JAMA Network Open.Jonathon …
Learn MorePosoleucel Efficacious for Stem Cell Transplant Recipients
TUESDAY, Jan. 17, 2023 (HealthDay News) — For recipients of allogeneic hematopoietic cell transplantation (allo-HCT) with refractory viral infections/disease, the T-cell therapy posoleucel is well tolerated and effective, according to a study publish…
Learn MoreRisk for Hydroxychloroquine Retinopathy 8.6 Percent at 15 Years
TUESDAY, Jan. 17, 2023 (HealthDay News) — The overall risk for hydroxychloroquine retinopathy is 8.6 percent after 15 years, according to a study published online Jan. 17 in the Annals of Internal Medicine.Ronald B. Melles, M.D., from Kaiser Permanen…
Learn MoreRecommendations Updated for Management of Celiac Disease
TUESDAY, Jan. 17, 2023 (HealthDay News) — In clinical guidelines published in the January issue of the American Journal of Gastroenterology, updated recommendations are presented for the evaluation and management of patients with celiac disease (CD),…
Learn MoreExtent of Tumor Resection Linked to Overall Survival in Low-Grade Glioma
TUESDAY, Jan. 17, 2023 (HealthDay News) — For patients with diffuse low-grade glioma, the extent of surgical tumor resection (EOR) is associated with overall survival (OS), with improved OS seen with EOR ≥75 percent, according to a study published on…
Learn More